Stents in the GI tract

Expert Review of Medical Devices

Volumn 4, Issue 5, 2007, Pages 741-752

  Homs, Marjolein Y V ^a   Siersema, Peter D ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Brachytherapy; Colon; Duodenum; Dysphagia; Esophageal cancer; Esophageal perforation; Gastric outlet obstruction; Obstruction; Palliation; Stent

Indexed keywords

POLYETHYLENE;

ASPIRATION PNEUMONIA; BILE DUCT CANCER; BOERHAAVE SYNDROME; BRACHYTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CARDIA CARCINOMA; CLINICAL TRIAL; COLORECTAL CANCER; DEVICE REMOVAL; DYSPHAGIA; EQUIPMENT DESIGN; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; ESOPHAGUS RUPTURE; ESOPHAGUS STRICTURE; ESOPHAGUS VARICES BLEEDING; GASTRECTOMY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL DISEASE; GASTROJEJUNOSTOMY; HUMAN; INTERMETHOD COMPARISON; OBSTRUCTIVE JAUNDICE; PROGNOSIS; PYLORUS STENOSIS; RETROSTERNAL PAIN; REVIEW; STENT; THERAPY EFFECT; TREATMENT INDICATION;

GASTROINTESTINAL DISEASES; HUMANS; STENTS;

EID: 34848927433     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/17434440.4.5.741     Document Type: Review

References (106)

1. Siersema PD, Hop WC, Dees J, Tilanus HW, van Blankenstein M. Coated self-expanding metal stents versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: a controlled, prospective study. Gastrointest. Endosc. 47(2), 113-120 (1998).
2. Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N. Engl. J. Med. 329(18), 1302-1307 (1993).
3. De Palma GD, di Matteo E, Romano G, Fimmano A, Rondinone G, Catanzano C. Plastic prosthesis versus expandable metal stents for palliation of inoperable esophageal thoracic carcinoma: a controlled prospective study. Gastrointest. Endosc. 43(5), 478-482 (1996).
4. Laasch HU, Martin DF, Do YS, Kocher M, Valette PJ. Interventional radiology for the management of inoperable carcinoma of the oesophagus. Endoscopy 35(12), 1049-1057 (2003).
5. Hubmann R, Bodlaj G, Czompo M et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy 38(9), 896-901 (2006).
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74-108 (2005).
7. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83(10), 2049-2053 (1998).
8. Bollschweller E, Wolfgarten E, Gutschow C, Holscher AH. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 92(3), 549-555 (2001).
9. Baron TH. Expandable metal stents for the treatment of cancerous obstruction of the gastrointestinal tract. N. Engl. J. Med. 344(22), 1681-1687 (2001).
10. Christie NA, Buenaventura PO, Fernando. HC et al. Results of expandable metal stents for malignant esophageal obstruction in 100 patients: short-term and long-term follow-up. Ann. Thorac. Surg. 71(6), 1797-1801 (2001).
11. Siersema PD, Hop WC, van Blankenstein M et al. A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: a prospective, randomized study. Gastrointest. Endosc. 54(2), 145-153 (2001).
12. Raijman I, Siddique I, Ajani J, Lynch P. Palliation of malignant dysphagia and fistulae with coated expandable metal stents: experience with 101 patients. Gastrointest. Endosc. 48(2), 172-179 (1998).
13. Vakil N, Morris AI, Marcon N et al. A prospective, randomized, controlled trial of covered expandable metal stents in the palliation of malignant esophageal obstruction at the gastroesophageal junction. Am. J, Gastroenterol. 96(6), 1791-1796 (2001).
14. Homs MY, Steyerberg EW, Kuipers EJ et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 36(10), 880-886 (2004).
15. Brewster AE, Davidson SE, Makin WP, Stout R, Burt PA. Intraluminal brachytherapy using the high dose rate microSelectron in the palliation of carcinoma of the oesophagus. Clin. Oncol. (R. Coll. Radiol.) 7(2), 102-105 (1995).
16. Jager J, Langendijk H, Pannebakker M, Rijken J, de Jong J. A single session of intraluminal brachytherapy in palliation of oesophageal cancer. Radiother. Oncol. 37(3), 237-240 (1995).
17. Sur RK, Levin CV, Donde B, Sharma V, Miszczyk L, Nag S. Prospective randomized trial of HDR brachytherapy as a sole modality in palliation of advanced esophageal carcinoma - an International Atomic Energy Agency study. Int. J. Radiat. Oncol. Biol. Phys. 53(1), 127-133 (2002).
18. Bergquist H, Wenger U, Johnsson E et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis. Esophagus 18(3), 131-139 (2005).
19. Homs MY, Steyerberg EW, Eijkenboom WM et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet 364 (9444), 1497-1504 (2004).
20. Dua KS. Stents for palliating malignant dysphagia and fistula: is the paradigm shifting? Gastrointest. Endosc. 65(1), 77-81 (2007).
21. Wenger U, Johnsson E, Arnelo U, Lundell L, Lagergren J. An antireflux stent versus conventional stents for palliation of distal esophageal or cardia cancer: a randomized clinical study. Surg. Endosc. 20(11), 1675-1680 (2006).
22. Shim CS, Jung IS, Cheon YK et al. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy 37(4), 335-339 (2005).
23. Osugi H, Lee S, Higashino M et al. Usefulness of self-expandable metallic stent with an antireflux mechanism as a palliation for malignant strictures at the gastroesophageal junction. Surg. Endosc. 16(10), 1478-1482 (2002).
24. Laasch HU, Marriott A, Wilbraham L, Tunnah S, England RE, Martin DF. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 225(2), 359-365 (2002).
25. Homs MY, Wahab PJ, Kuipers EJ et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial. Gastrointest. Endosc. 60(5), 695-702 (2004).
26. Dua KS, Kozarek R, Kim J et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest. Endosc. 53(6), 603-613 (2001).
27. Do YS, Choo SW, Suh SW et al. Malignant esophagogastric junction obstruction: palliative treatment with an antireflux valve stent. J. Vasc. Interv. Radiol. 12(5), 647-651 (2001).
28. Dormann AJ, Eisendrath P. Wigginghaus B, Huchzermeyer H, Deviere J. Palliation of esophageal carcinoma with a new self-expanding plastic stent. Endoscopy 35(3), 207-211 (2003).
29. Mayoral W, Fleischer D, Salcedo J, Roy P, Al-Kawas F, Benjamin S. Nonmalignant obstruction is a common problem with metal stents in the treatment of esophageal cancer. Gastrointest. Endosc. 51(5), 556-559 (2000).
30. Verschuur EM, Horns MY, Steyerberg EW et al. A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients. Gastrointest. Endosc. 63(1), 134-140 (2006).
31. Verschuur EM, Repici A, Kuipers EJ, Steyerberg EW, Siersema PD. New design esophageal stents for the palliation of dysphagia from esophageal or gastric cardia cancer: a randomized trial. Am. J. Gastroenterol. (2007) (In Press).
32. Dumonceau JM, Cremer M, Lalmand B, Deviere J. Esophageal fistula sealing: choice of stent, practical management, and cost. Gastrointest. Endosc. 49(1), 70-78 (1999).
33. Siersema PD, Schrauwen SL, van Blankenstein M et al. Self-expanding metal stents for complicated and recurrent esophagogastric cancer. Gastrointest. Endosc. 54(5), 579-586 (2001).
34. Morgan RA, Ellul JP, Denton ER, Glynos M, Mason RC, Adam A. Malignant esophageal fistulas and perforations: management with plastic-covered metallic endoprostheses. Radiology 204(2). 527-532 (1997).
35. Gislason GT, Pasricha PJ. Crossing the upper limit: esophageal stenting in the proximal esophagus. Dysphagia 12(2), 84-85 (1997).
36. Loizou LA, Rampton D, Bown SG: Treatment of malignant strictures of the cervical esophagus by endoscopic intubation using modified endoprostheses. Gastrointest. Endosc. 38(2), 158-164 (1992).
37. Eleftheriadis E, Kotzampassi K. Endoprosthesis implantation at the pharyngo-esophageal level: problems, limitations and challenges. World J. Gastroenterol. 12(13), 2103-2108 (2006).
38. Profili S, Meloni GB, Feo CF et al. Self-expandable metal stents in the management of cervical oesophageal and/or hypopharyngeal strictures. Clin. Radiol. 57(11), 1028-1033 (2002).
39. Bethge N, Sommer A, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest. Endosc. 45(3), 300-303 (1997).
40. Conio M, Caroli-Bosc F, Demarquay JF et al. Self-expanding metal stents in the palliation of neoplasms of the cervical esophagus. Hepatogastroenterology'46(25), 272-277 (1999).
41. Verschuur EM, Kuipers EJ, Siersema PD. Esophageal stents for malignant strictures close to the upper esophageal sphincter. Gastrointest. Endosc. (2007) (In Press).
42. Shim CS, Jung IS, Bhandari S et al. Management of malignant strictures of the cervical esophagus with a newly-designed self-expanding metal stent. Endoscopy 36(6), 554-557 (2004).
43. Conio M, Blanchi S, Filiberti R et al. A modified self-expanding Niti-S stent for the management of benign hypopharyngeal strictures. Gastrointest. Endosc. 65(4), 714-720 (2007).
44. Walker WS, Cameron EW, Walbaum PR. Diagnosis and management of spontaneous transmural rupture of the oesophagus (Boerhaave's syndrome). Br. J. Surg. 72(3), 204-207 (1985).
45. Brinster CJ, Singhal S, Lee L, Marshall MB, Kaiser LR, Kucharczuk JC. Evolving options in the management of esophageal perforation. Ann. Thorac. Surg. 77(4). 1475-1483 (2004).
46. Zwischenberger JB, Savage C, Bidani A. Surgical aspects of esophageal disease: perforation and caustic injury. Am. J. Respir. Crit. Care Med. 165(8), 1037-1040 (2002).
47. Tilanus HW, Bossuyt P, Schattenkerk ME, Obertop H. Treatment of oesophageal perforation: a multivariate analysis. Br. J. Surg. 78(5), 582-585 (1991).
48. Petersen B, Barkun A, Carpenter S et al. Tissue adhesives and fibrin glues. Gastrointest. Endosc. 60(3), 327-333 (2004).
49. Raju GS, Thompson C, Zwischenberger JB. Emerging endoscopic options in the management of esophageal leaks (videos). Gastrointest. Endosc. 62(2), 278-286 (2005).
50. Peters JH. Craanen ME, van der Peet DL, Cuesta MA, Mulder CJ. Self-expanding metal stents for the treatment of intrathoracic esophageal anastomotic leaks following esophagectomy. Am. J. Gastroenterol. 101 (6), 1393-1395 (2006).
51. Schubert D, Scheidbach H, Kuhn R et al. Endoscopic treatment of thoracic esophageal anastomotic leaks by using silicone-covered, self-expanding polyester stents. Gastrointest. Endosc. 61(7), 891-896 (2005).
52. Lee JG, Hsu R, Leung JW. Are self-expanding metal mesh stents useful in the treatment of benign esophageal stenoses and fistulas? An experience of four cases. Am. J. Gastroenterol. 95(8), 1920-1925 (2000).
53. Chung MG, Kang DH, Park DK, Park JJ, Park HC, Kim JH. Successful treatment of Boerhaave's syndrome with endoscopic insertion of a self-expandable metallic stent: report of three cases and a review of the literature. Endoscopy 33(10), 894-897 (2001).
54. Wadhwa RP, Kozarek RA, France RE et al. Use of self-expandable metallic stents in benign GI diseases. Gastrointest. Endosc. 58(2), 207-212 (2003).
55. Siersema PD, Homs MY, Haringsma J, Tilanus HW, Kuipers EJ. Use of large-diameter metallic stents to seal traumatic nonmalignant perforations of the esophagus. Gastrointest. Endosc. 58(3), 356-361 (2003).
56. Doniec JM, Schniewind B, Kahlke V, Kremer B, Grimm H. Therapy of anastomotic leaks by means of covered self-expanding metallic stents after esophagogastrectomy. Endoscopy 35(8), 652-658 (2003).
57. Evrard S, Le Moine O, Lazaraki G, Dormann A, El Nakadi I, Deviere J. Self-expanding plastic stents for benign esophageal lesions. Gastrointest. Endosc. 60(6), 894-900 (2004).
58. Gelbmann CM, Ratiu NL, Rath HC et al. Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks. Endoscopy 36(8), 695-699 (2004).
59. Hunerbein M, Stroszczynski C, Moesta KT, Schlag PM. Treatment of thoracic anastomotic leaks after esophagectomy with self-expanding plastic stents. Ann. Surg. 240(5), 801-807 (2004).
60. Langer FB, Wenzl E, Prager G et al. Management of postoperative esophageal leaks with the Polyflex self-expanding covered plastic stent. Ann. Thorac. Surg. 79(2), 398-403 (2005).
61. Radecke K, Gerken G, Treichel U. Impact of a self-expanding, plastic esophageal stent on various esophageal stenoses, fistulas, and leakages: a single-center experience in 39 patients. Gastrointest. Endosc. 61(7), 812-818 (2005).
62. Lyburn I, Blazeby JM, Barham P, Loveday E. Palliation of malignant gastric outlet obstruction after oesophagectomy by percutaneous transthoracic placement of an expanding metal stent. Clin. Radiol. 56(1), 82-83 (2001).
63. Law S, Tung PH, Chu KM, Wong J. Self-expanding metallic stents for palliation of recurrent malignant esophageal obstruction after subtotal esophagectomy for cancer. Gastrointest. Endosc. 50(3), 427-436 (1999).
64. Bethge N, Sommer A, von Kleist D, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal obstruction after failure of primary curative therapy. Gastrointest. Endosc. 44(3), 283-286 (1996).
65. Perez-Roldan F, Gonzalez-Carro P, Legaz-Huidobro M et al. Esophagoenteral stents in patients with recurrent gastric adenocarcinoma. Rev. Esp. Enferm. Dig. 98(5), 341-349 (2006).
66. Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am. J. Gastroenterol. 97(1), 72-78 (2002).
67. Espinel J, Vivas S, Munoz F, Jorquera F, Olcoz JL. Palliative treatment of malignant obstruction of gastric outlet using an endoscopically placed enteral Wallstent. Dig. Dis. Sci. 46(11), 2322-2324 (2001).
68. Lopera JE, Brazzini A, Gonzales A, Castaneda-Zuniga WR. Gastroduodenal stent placement: current status. Radiographics 24(6), 1561-1573 (2004).
69. Lillemoe KD, Cameron JL, Hardacre JM et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann. Surg. 230(3), 322-328 (1999).
70. Del Piano M, Ballare M, Montino F et al. Endoscopy or surgery for malignant GI outlet obstruction? Gastrointest. Endosc, 61(3), 421-426 (2005).
71. Wong YT, Brams DM, Munson L et al. Gastric outlet obstruction secondary to pancreatic cancer: surgical vs endoscopic palliation. Surg. Endosc. 16(2), 310-312 (2002).
72. Bessoud B, de Baere T, Denys A et al. Malignant gastroduodenal obstruction: palliation with self-expanding metallic stents. J. Vasc. Interv. Radiol. 16(2 Pt 1), 247-253 (2005).
73. Brune IB, Feussner H, Neuhaus H, Classen M, Siewert JR. Laparoscopic gastrojejunostomy and endoscopic biliary stent placement for palliation of incurable gastric outlet obstruction with cholestasis. Surg. Endosc. 11(8), 834-837 (1997).
74. Holt AP, Patel M, Ahmed MM. Palliation of patients with malignant gastroduodenal obstruction with self-expanding metallic stents: the treatment of choice? Gastrointest. Endosc. 60(6), 1010-1017 (2004).
75. Kim JH, Yoo BM, Lee KJ et al. Self-expanding coil stent with a long delivery system for palliation of unresectable malignant gastric outlet obstruction: a prospective study. Endoscopy 33(10), 838-842 (2001).
76. Telford JJ, Carr-Locke DL, Baron TH et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest. Endosc. 60(6), 916-920 (2004).
77. Song HY, Shin JH, Yoon CJ et al. A dual expandable nitinol stent: experience in 102 patients with malignant gastroduodenal strictures. J. Vasc. Interv. Radiol. 15(12), 1443-1449 (2004).
78. Jeurnink SM, van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol. 7, 18 (2007).
79. Fiori E, Lamazza A, Volpino P et al. Palliative management of malignant antro-pyloric strictures. Gastroenterostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 24(1), 269-271 (2004).
80. Mehta S, Hindmarsh A, Cheong E et al. Prospective randomized trial of laparoscopic gastrojejunostomy versus duodenal stenting for malignant gastric outflow obstruction. Surg. Endosc. 20(2), 239-242 (2006).
81. Moss AC, Morris E, MacMathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst. Rev. 2, CD004200 (2006).
82. Lichtenstein DR, Carr-Locke DL. Endoscopic palliation for unresectable pancreatic carcinoma. Surg. Clin. North Am. 75(5), 969-988 (1995).
83. Somogyi L, Chuttani R, Croffie J et al. Biliary and pancreatic stents. Gastrointest. Endosc. 63(7), 910-919 (2006).
84. Katsinelos P, Paikos D, Kountouras J et al. Tannenbaum and metal stents in the palliative treatment of malignant distal bile duct obstruction: a comparative study of patency and cost effectiveness. Surg. Endosc. 20(10), 1587-1593 (2006).
85. Carr-Locke DL, Ball TJ, Connors PJ et al. Multicenter randomized trial of Wallstent biliary endoprosthesis versus plastic stents. Gastrointest. Endosc. 39, A310 (1993).
86. Kaassis M, Boyer J, Dumas R et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest. Endosc. 57(2), 178-182 (2003).
87. Lammer J, Hausegger KA, Fluckiger F et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology 201(1), 167-172 (1996).
88. Prat F, Chapat O, Ducot B et al. A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct. Gastrointest. Endosc. 47(1), 1-7 (1998).
89. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 340(8834-8835), 1488-1492 (1992).
90. Knyrim K, Wagner HJ, Pausch J, Vakil N. A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct. Endoscopy 25(3), 207-212 (1993).
91. Schmassmann A, von Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am. J. Gastroenterol. 91(4), 654-659 (1996).
92. Isayama H, Komatsu Y, Tsujino T et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 53(5), 729-734 (2004).
93. Park do H, Kim MH, Choi JS et al. Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin. Gastroenterol. Hepatol. 4(6), 790-796 (2006).
94. Yoon WJ, Lee JK, Lee KH et al. A comparison of covered and uncovered Wallstents for the management of distal malignant biliary obstruction. Gastrointest. Endosc. 63(7), 996-1000 (2006).
95. Miyayama S, Matsui O, Akakura Y et al. Efficacy of covered metallic stents in the treatment of unresectable malignant biliary obstruction. Cardiovasc. Intervent. Radiol. 27(4), 349-354 (2004).
96. Arguedas MR, Heudebert GH, Stinnett AA, Wilcox CM. Biliary stents in malignant obstructive jaundice due to pancreatic carcinoma: a cost-effectiveness analysis. Am. J. Gastroenterol. 97(4), 898-904 (2002).
97. Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest. Endosc. 49(4 Pt 1), 466-471 (1999).
98. Harris GJ, Senagore AJ, Lavery IC, Fazio VW. The management of neoplastic colorectal obstruction with colonic endolumenal stenting devices. Am. J. Surg. 181(6), 499-506 (2001).
99. Dohmoto M. New method - endoscopic implantation of rectal stents in palliative treatment of malignant stenosis. Endoscopia Digestiva 3, 1507-1512 (1991).
100. Ptok H, Meyer F, Marusch F et al. Palliative stent implantation in the treatment of malignant colorectal obstruction. Surg. Endosc. 20(6), 909-914 (2006).
101. Mucci-Hennekinne S, Kervegant AG, Regenet N et al. Management of acute malignant large-bowel obstruction with self-expanding metal stent. Surg. Endosc. 21(7), 1101-1103 (2007).
102. Targownik LE, Spiegel BM, Sack J et al. Colonic stent vs emergency surgery for management of acute left-sided malignant colonic obstruction: a decision analysis. Gastrointest. Endosc. 60(6), 865-874 (2004).
103. Laasch HU, Wilbraham L, Marriott A, Martin DF. Treatment of colovaginal fistula with coaxial placement of covered and uncovered stents. Endoscopy 35(12), 1081 (2003).
104. Tilney HS, Lovegrove RE, Purkayastha S et al. Comparison of colonic stenting and open surgery for malignant large bowel obstruction. Surg. Endosc. 21(2), 225-233 (2007).
105. Fiori E, Lamazza A, De Cesare A et al. Palliative management of malignant rectosigmoidal obstruction. Colostomy vs. endoscopic stenting. A randomized prospective trial. Anticancer Res. 24(1), 265-268 (2004).
106. Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions? Results of a study and cost-effectiveness analysis. Surg. Endosc. 18(3), 421-426 (2004).